Abstract:Strong evidence indicates critical roles of NADPH oxidase (a key superoxide-producing enzyme complex during inflammation) in activated microglia for mediating neuroinflammation and neurodegeneration. However, little is known about roles of neuronal NADPH oxidase in neurodegenerative diseases. This study aimed to investigate expression patterns, regulatory mechanisms and pathological roles of neuronal NADPH oxidase in inflammation-associated neurodegeneration. The results showed persistent upregulation of NOX2 (gp91phox; the catalytic subunit of NADPH oxidase) in both microglia and neurons in a chronic mouse model of Parkinson's disease (PD) with intraperitoneal LPS injection and LPS-treated midbrain neuron-glia cultures (a cellular model of PD). Notably, NOX2 was found for the first time to exhibit a progressive and persistent upregulation in neurons during chronic neuroinflammation. While primary neurons and N27 neuronal cells displayed basal expression of NOX1, NOX2 and NOX4, significant upregulation only occurred in NOX2 but not NOX1 or NOX4 under inflammatory conditions. Persistent NOX2 upregulation was associated with functional outcomes of oxidative stress including increased ROS production and lipid peroxidation. Neuronal NOX2 activation displayed membrane translocation of cytosolic p47phox subunit and was inhibited by apocynin and diphenyleneiodonium chloride (two widely-used NADPH oxidase inhibitors). Importantly, neuronal ROS production, mitochondrial dysfunction and degeneration induced by inflammatory mediators in microglia-derived conditional medium were blocked by pharmacological inhibition of neuronal NOX2. Furthermore, specific deletion of neuronal NOX2 prevented LPS-elicited dopaminergic neurodegeneration in neuron-microglia co-cultures separately grown in the transwell system. The attenuation of inflammation-elicited upregulation of NOX2 in neuron-enriched and neuron-glia cultures by ROS scavenger N-acetylcysteine indicated a positive feedback mechanism between excessive ROS production and NOX2 upregulation. Collectively, our findings uncovered crucial contribution of neuronal NOX2 upregulation and activation to chronic neuroinflammation and inflammation-related neurodegeneration. This study reinforced the importance of developing NADPH oxidase-targeting therapeutics for neurodegenerative diseases.

Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases

Redox control of microglial function: molecular mechanisms and functional significance

Redox Regulation of Inflammation: Old Elements, a New Story.

Generation of Reactive Oxygen Species (ROS) and Pro-Inflammatory Signaling in Human Brain Cells in Primary Culture.

Redox Signaling at the Crossroads of Human Health and Disease

Reactive oxygen species, cell signaling, and cell injury

ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease

Signaling by reactive oxygen species in the nervous system

Redox control of the survival of healthy and diseased cells.

NADPH Oxidases in the Central Nervous System: Regional and Cellular Localization and the Possible Link to Brain Diseases

ROS signaling in innate immunity via oxidative protein modifications

ROS Function in Redox Signaling and Oxidative Stress

The key roles of reactive oxygen species in microglial inflammatory activation: Regulation by endogenous antioxidant system and exogenous sulfur-containing compounds

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications

Activation of Neuronal NADPH Oxidase NOX2 Promotes Inflammatory Neurodegeneration

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Redox Regulation of Inflammatory Processes Is Enzymatically Controlled

Redox regulation of macrophages

Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders

The Interrelation Between Reactive Oxygen Species and Autophagy in Neurological Disorders